Varicella zoster virus vaccines: effective, but concerns linger.

@article{Liesegang2009VaricellaZV,
  title={Varicella zoster virus vaccines: effective, but concerns linger.},
  author={T. Liesegang},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2009},
  volume={44 4},
  pages={
          379-84
        }
}
  • T. Liesegang
  • Published 2009
  • Medicine
  • Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
  • Both varicella and herpes zoster (HZ) can cause severe disease in certain age groups. The cell-mediated immune (CMI) response to the varicella zoster virus (VZV) is critical in preventing a recurrence of VZV. The varicella vaccine has markedly decreased the morbidity and mortality associated with varicella, but concerns linger about the cost and frequency of vaccine administration and the long-term effects on both adult varicella and HZ epidemiology in the individual and in the population… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 65 REFERENCES
    Vaccination to prevent herpes zoster in older adults.
    • 38
    Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.
    • 371
    • PDF
    Effects of varicella vaccination on herpes zoster incidence.
    • 23